Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$10.18 - $18.4 $819,866 - $1.48 Million
-80,537 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$7.51 - $11.72 $1.68 Million - $2.62 Million
-223,314 Reduced 73.49%
80,537 $839,000
Q2 2021

Aug 16, 2021

SELL
$8.69 - $11.08 $219,674 - $280,091
-25,279 Reduced 7.68%
303,851 $2.73 Million
Q1 2021

May 14, 2021

BUY
$8.89 - $14.92 $2.93 Million - $4.91 Million
329,130 New
329,130 $3.34 Million

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $390M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.